Details for Patent: 12,109,277
✉ Email this page to a colleague
Which drugs does patent 12,109,277 protect, and when does it expire?
Patent 12,109,277 protects LOCAMETZ and is included in one NDA.
This patent has seventeen patent family members in nine countries.
Summary for Patent: 12,109,277
| Title: | Methods and kits for preparing radionuclide complexes |
| Abstract: | A method for preparing a complex comprising a radioisotope of gallium for use in radiotherapy or in a medical imaging procedure, said method comprising adding a gallium radioisotope solution obtained directly from a gallium radionuclide generator to a composition comprising a pharmaceutically acceptable buffer and optionally also a pharmaceutically acceptable basic reagent, in amounts sufficient to increase the pH to a level in the range of 3 to 8, wherein the composition further comprises a chelator that is able to chelate radioactive gallium within said pH range and at moderate temperature, said chelator being optionally linked to a biological targeting agent. Kits and compositions for use in the method are also described and claimed. |
| Inventor(s): | Philip Blower, Gregory Mullen |
| Assignee: | Theragnostics Ltd , Kings College London |
| Application Number: | US18/499,758 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; |
Drugs Protected by US Patent 12,109,277
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | LOCAMETZ | gallium ga-68 gozetotide | POWDER;INTRAVENOUS | 215841-001 | Mar 23, 2022 | RX | Yes | Yes | 12,109,277 | ⤷ Start Trial | POSITRON EMISSION TOMOGRAPHY (PET) OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-POSITIVE LESIONS IN MEN WITH PROSTATE CANCER | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,109,277
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2016230890 | ⤷ Start Trial | |||
| Canada | 2979127 | ⤷ Start Trial | |||
| China | 107438615 | ⤷ Start Trial | |||
| European Patent Office | 3268337 | ⤷ Start Trial | |||
| Spain | 2794581 | ⤷ Start Trial | |||
| United Kingdom | 201504064 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
